Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 925-934

  Chandrasekar, Bysani ^a   Melby, Peter C ^a   Troyer, Dean A ^a   Colston, James Thompson ^a   Freeman, Gregory Lane ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; GENE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRYPANOSOMA CRUZI;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHAGAS CARDIOMYOPATHY; CYTOKINES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; TIME FACTORS; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031944694     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M: Chagas' disease. Clin Microbiol Rev 1992, 5:400-419
2. Hagar JM, Rahimtoola SH: Chagas heart disease. Curr Probl Cardiol 1995, 20:827-924
3. Andrade ZA: Pathogenesis of Chagas' disease. Res Immunol 1991, 142:126-129
4. Rossi MA, Bestetti RB: The challenge of Chagasic cardiomyopathy. Cardiology 1995, 86:1-7
5. Tanowitz HB, Morris SA, Factor SM, Weiss LM, Wittner M: Parasitic diseases of the heart. I. Acute and chronic Chagas' disease. Cardiovasc Pathol 1992, 1:7-16
6. Andrade ZA: Mechanisms of myocardial damage in Trypanosoma cruzi infection. Cytopathology of Parasitic Disease, Ciba Foundation Symposium 99. London, Pitman Books, 1983, pp 214
7. Tarleton RL: Tumor necrosis factor (cachectin) production during experimental Chagas' disease. Clin Exp Immunol 1988, 73:186-190
8. Titus RG, Sherry B, Cerami A: The involvement of TNF, IL-1, and IL-6 in the immune response to protozoan parasites. Immunol Today 1991, 12:A13-A16
9. Rivera MT, Marques de Araujo S, Lucas R, Deman J, Truyens C, Defresne MP, de Baetselier P, Carlier Y: High tumor necrosis factor α (TNF-α) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-α gene transcription in their offspring. Infect Immun 1995, 63:591-595
10. Chandrasekar B, Melby PC, Troyer DA, Freeman GL: Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy. Biochem Biophys Res Commun 1996, 223:365-371
11. Abel FL: Myocardial function in sepsis and endotoxin shock. Am J Physiol 1989, 257:R1265-R1281
12. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287
13. Zentella A, Manogue K, Cerami A: The role of cachectin/TNF and other cytokines in sepsis. Prog Clin Biol Res 1991, 367:9-24
14. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C: Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 1992, 263: H668-H675
15. Fahey TJ III, Yoshioka T, Shires TG, Fantini GA: The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann Surg 1996, 223:63-69
16. Murray DR, Freeman GL: Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996, 78:154-160
17. Hosenpud JD: The effects of interleukin 1 on myocardial function and metabolism. Clin Immunol Immunopathol 1993, 68:175-180
18. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR: Interleukin-1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 1992, 175: 1123-1129
19. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72:561-566
20. Herskowitz A, Choi S, Ansari AA, Wesselingh S: Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995, 146:419-428
21. Chandrasekar B, Colston JT, Freeman GL: Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischemia. Clin Exp Immunol 1997, 108:346-351
22. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Pimentai D, Michael T, Smith TW: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993, 91:2314-2319
23. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart are mediated by nitric oxide. Science 1992, 257:387-389
24. Postan M, McDaniel JHP, Dvorak JA: Comparative studies of the infection of Lewis rats with four Trypanosoma cruzi clones. Trans R Soc Trop Med Hyg 1987, 80:415-419
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid-guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
26. Chandrasekar B, Streitman JE, Colston JT, Freeman GF: Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric oxide synthase in postischemic myocardium. Biochim Biophys Acta 1998 (in press)
27. Freeman GL, Colston JT, Zabalgoitia M, Chandrasekar B: Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol 1998, 274:H249-H258
28. Masters DB, Griggs CT, Berde CB: High sensitivity quantification of RNA from gels and autoradiograms with affordable optical scanning. Biotechniques 1992, 12:902-911
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
30. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
31. Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowicz M: Is TNFα involved in early susceptibility of Trypanosoma cruzi-infected C3H/HeJ mice? Res Immunol 1991, 142:117-122
32. Hunter CA, Slifer T, Araujo F: Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor α and γ interferon. Infect Immun 1996, 64:2381-2386
33. Zhang L, Tarleton RL: Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 1996, 26:102-109
34. Truyens C, Angelo-Barrios A, Torrico F, Van Damme J, Heremans H, Carlier Y: Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect Immun 1994, 62:692-696
35. Pagani FD, Baker LS, Hsi C, Know M, Fink MP, Visner MS: Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992, 90:389-398
36. Sehgal PB: Regulation of IL6 gene expression. Res Immunol 1992, 143:724-734
37. Le J, Vilcek J: Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987, 56:234-248
38. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 1993, 328:106-113
39. Kelly RA, Balligand J-L, Smith T: Nitric oxide and cardiac function. Circ Res 1996, 79:363-380
40. Rottenberg ME, Castanos-Velez E, de Mesquita R, Laguardia OG, Biberfeld P, Orn A: Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Eur J Immunol 1996, 26:3203-3213
41. Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM: Inhibition of cytokine-induced nitric oxide production by transforming growth factor β1 in human smooth muscle cells. J Physiol 1992, 454:451-465
42. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billia TR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993, 90:522-526
43. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M: Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996, 28:1631-1639
44. Baeuerle PA, Baltimore D: The physiology of NF-κB transcription factor. Molecular Aspects of Cellular Regulation, Hormonal Control, Regulation of Gene Transcription. Edited by Cohen P, Foulkes JG. Amsterdam, Elsevier, 1991, pp 409
45. Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in the cytotoxicity. Proc Natl Acad Sci USA 1995, 92:8115-8119
46. Schreck R, Baeuerle PA; Assessing oxygen radicals as mediators in activation of inducible transcription factor NF-kappa B. Methods Enzymol 1994, 234:151-163
47. Chandrasekar B, Freeman GL: Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett 1997, 401:30-34
48. Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994, 269:4705-4709
49. Goldring CEP, Narayanan R, Lagadec P, Jeannin J-F: Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB/rel proteins. Biochem Biophys Res Commun 1995, 209:73-79